glp 1 gip glucagon triple agonist The Effects of Dual GLP-1/GIP Receptor Agonism on Secretion—A Review Calling retatrutide a “GLP-3” is
Description
Long, J
Diabetes, Obesity and Metabolism, 16(1), 921
doi: 10.18632/aging.202564 302 ZhouYLanHDongZLiWQianBZengZet al
Diabetes Res Clin Pract (2012) 98(2):27184
GLP-1 receptor agonists demonstrate modest but clinically relevant effects on lipid profiles , though they are not primarily indicated for cholesterol management
however, these findings have not been consistently replicated in humans, including data from large-scale clinical trials (Davies et al., 2021
